1990: Launch of Norris
1992: Launch of Ethical Division and conversion of company into Public Limited company
1994: WHO cGMP Certificate
1995: Major Expansions
1996: Started exporting to European, Middle East, Far East and African Countries
2006: Launching of Diabetic & Cardiac products
2007: Launching of Dental product range
2012: Launching of New Molecule Tolperisone with Paracetamol tablet
2013: Extension in Anti malarial range with Artemether Lumefantrine tablet & dry syrup
